KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions-Reference-Cited by-同舟云学术

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions

Published:2016-04-26 Issue:5 Volume:17 Page:625
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Nakamura Kohei,Nakayama Kentaro,Ishibashi Tomoka,Ishikawa Noriyoshi,Ishikawa Masako,Katagiri Hiroshi,Minamoto Toshiko,Sato Emi,Sanuki Kaori,Yamashita Hitomi,Iida Kouji,Sultana Razia,Kyo Satoru

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/5/625/pdf

Reference14 articles.

1. Global cancer statistics

2. Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma

3. Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges

4. Molecular genetic analysis of ovarian serous cystadenomas

5. Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current concept of low-grade serous ovarian carcinoma;Translational Cancer Research;2024-01

2. Simultaneous p53 and KRAS mutation in a high-grade serous carcinoma with deceptive appearance of a low-grade carcinoma. A case report;Gynecologic Oncology Reports;2023-06

3. Precursors in the ovarian stroma: another pathway to explain the origin of ovarian serous neoplasms;Human Pathology;2022-09

4. Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells;Cancers;2022-03-15

5. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis;Molecular and Cellular Biochemistry;2022-02-15